Paper23102497
Deficient mismatch repair phenotype is a prognostic factor for colorectal cancer in elderly patients.
Aparicio T and 13 others. Dig Liver Dis, 2013. Cited by 32 papers, by iCite.
Cite this record
ConductScience Library. Deficient mismatch repair phenotype is a prognostic factor for colorectal cancer in elderly patients. Papers, record 23102497. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/23102497
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Deficient mismatch repair phenotype is a prognostic factor for colorectal cancer in elderly patients.
- PubMed
Topics15
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Adenocarcinoma | Major topic |
| Colorectal Neoplasms | Major topic |
| DNA Mismatch Repair | Major topic |
| Microsatellite Instability | Major topic |
| Age Factors | |
| Aged | |
| Aged, 80 and over | |
| DNA Methylation | |
| Disease-Free Survival | |
| Female | |
| Humans | |
| Male | |
| Phenotype | |
| Prognosis | |
| Retrospective Studies |
Source PubMed
Cited by16
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 32 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 40141143 | Polyphenol Intake in Elderly Patients: A Novel Approach to Counteract Colorectal Cancer Risk? | Int J Mol Sci | 2025 | https://conductscience.org/library/papers/40141143 | PubMed |
| 39847281 | Risk of Lymph Node Metastasis in T2 Colon Cancer: A Nationwide Population-Based Cohort Study. | Ann Surg Oncol | 2025 | https://conductscience.org/library/papers/39847281 | PubMed |
| 39640494 | Aging and cancer: Clinical role of tumor markers in the geriatric population (Review). | Med Int (Lond) | 2024 | https://conductscience.org/library/papers/39640494 | PubMed |
| 38948479 | Navigating through novelties concerning mCRC treatment-the role of immunotherapy, chemotherapy, and targeted therapy in mCRC. | Front Surg | 2024 | https://conductscience.org/library/papers/38948479 | PubMed |
| 38818960 | Lymphatic spread patterns in young versus elderly patients with stage III colon cancer. | BJS Open | 2024 | https://conductscience.org/library/papers/38818960 | PubMed |
| 38547438 | Oxaliplatin-Based Adjuvant Chemotherapy in Older Patients With Stage III Colon Cancer: An ACCENT/IDEA Pooled Analysis of 12 Trials. | J Clin Oncol | 2024 | https://conductscience.org/library/papers/38547438 | PubMed |
| 37052812 | Guidance for Treating the Older Adults with Colorectal Cancer. | Curr Treat Options Oncol | 2023 | https://conductscience.org/library/papers/37052812 | PubMed |
| 34143421 | Management of Metastatic Colorectal Carcinoma in Older Adults: Balancing Risks and Benefits of Novel Therapies. | Drugs Aging | 2021 | https://conductscience.org/library/papers/34143421 | PubMed |
| 33604737 | Rate of dissemination and prognosis in early and advanced stage colorectal cancer based on microsatellite instability status: systematic review and meta-analysis. | Int J Colorectal Dis | 2021 | https://conductscience.org/library/papers/33604737 | PubMed |
| 32823998 | Adjuvant Chemotherapy in Elderly Colorectal Cancer Patients. | Cancers (Basel) | 2020 | https://conductscience.org/library/papers/32823998 | PubMed |
| 30411662 | Prognostic Value of Mismatch Repair Genes for Patients With Colorectal Cancer: Meta-Analysis. | Technol Cancer Res Treat | 2018 | https://conductscience.org/library/papers/30411662 | PubMed |
| 29713641 | Treatment of Elderly Patients with Colorectal Cancer. | Biomed Res Int | 2018 | https://conductscience.org/library/papers/29713641 | PubMed |
| 29071260 | Effect of Adjuvant Chemotherapy on Elderly Colorectal Cancer Patients: Lack of Evidence. | Gastrointest Tumors | 2017 | https://conductscience.org/library/papers/29071260 | PubMed |
| 26770629 | Human mutL homolog 1 expression characteristic and prognostic effect on patients with sporadic colorectal cancer. | Int J Clin Exp Med | 2015 | https://conductscience.org/library/papers/26770629 | PubMed |
| 25973534 | Combination of microsatellite instability and BRAF mutation status for subtyping colorectal cancer. | Br J Cancer | 2015 | https://conductscience.org/library/papers/25973534 | PubMed |
| 24196786 | Small bowel adenocarcinoma phenotyping, a clinicobiological prognostic study. | Br J Cancer | 2013 | https://conductscience.org/library/papers/24196786 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| MLH1 | 4292 | PubTator's text mining | https://conductscience.org/library/genes/4292 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/23102497
GET https://conductscience.org/api/papers/v1/23102497/authors